| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |